Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 190

1.

Unexpected timely fracture union in matrix metalloproteinase 9 deficient mice.

Yuasa M, Saito M, Molina C, Moore-Lotridge SN, Benvenuti MA, Mignemi NA, Okawa A, Yoshii T, Schwartz HS, Nyman JS, Schoenecker JG.

PLoS One. 2018 May 31;13(5):e0198088. doi: 10.1371/journal.pone.0198088. eCollection 2018.

2.

Surgical Outcomes After Limb-Sparing Resection and Reconstruction for Pelvic Sarcoma: A Systematic Review.

Wilson RJ, Freeman TH Jr, Halpern JL, Schwartz HS, Holt GE.

JBJS Rev. 2018 Apr;6(4):e10. doi: 10.2106/JBJS.RVW.17.00072.

PMID:
29688908
3.

Development of a modular fluorescence overlay tissue imaging system for wide-field intraoperative surgical guidance.

Nguyen JQM, McWade M, Thomas G, Beddard BT, Herington JL, Paria BC, Schwartz HS, Halpern JL, Holt GE, Mahadevan-Jansen A.

J Med Imaging (Bellingham). 2018 Apr;5(2):021220. doi: 10.1117/1.JMI.5.2.021220. Epub 2018 Mar 2.

PMID:
29531968
4.

Pre-operative evaluation prior to soft tissue sarcoma excision - Why can't we get it right?

Mesko NW, Wilson RJ, Lawrenz JM, Mathieu JL, Ghiam MK, Mathis SL, Halpern JL, Schwartz HS, Holt GE.

Eur J Surg Oncol. 2018 Feb;44(2):243-250. doi: 10.1016/j.ejso.2017.11.001. Epub 2017 Nov 20.

PMID:
29269109
5.

Cost-utility of osteoarticular allograft versus endoprosthetic reconstruction for primary bone sarcoma of the knee: A markov analysis.

Wilson RJ, Sulieman LM, VanHouten JP, Halpern JL, Schwartz HS, Devin CJ, Holt GE.

J Surg Oncol. 2017 Mar;115(3):257-265. doi: 10.1002/jso.24525. Epub 2017 Jan 20.

PMID:
28105636
6.

CORR Insights®: Are Recently Trained Tumor Fellows Performing Less Tumor Surgery? An Analysis of 10 Years of the ABOS Part II Database.

Schwartz HS.

Clin Orthop Relat Res. 2017 Jan;475(1):229-231. doi: 10.1007/s11999-016-5086-7. Epub 2016 Oct 26. No abstract available.

7.

Intraoperative Raman spectroscopy of soft tissue sarcomas.

Nguyen JQ, Gowani ZS, O'Connor M, Pence IJ, Nguyen TQ, Holt GE, Schwartz HS, Halpern JL, Mahadevan-Jansen A.

Lasers Surg Med. 2016 Oct;48(8):774-781. doi: 10.1002/lsm.22564. Epub 2016 Jul 25.

8.

Plasmin Prevents Dystrophic Calcification After Muscle Injury.

Mignemi NA, Yuasa M, Baker CE, Moore SN, Ihejirika RC, Oelsner WK, Wallace CS, Yoshii T, Okawa A, Revenko AS, MacLeod AR, Bhattacharjee G, Barnett JV, Schwartz HS, Degen JL, Flick MJ, Cates JM, Schoenecker JG.

J Bone Miner Res. 2017 Feb;32(2):294-308. doi: 10.1002/jbmr.2973. Epub 2016 Dec 5.

9.

Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology.

von Mehren M, Randall RL, Benjamin RS, Boles S, Bui MM, Conrad EU 3rd, Ganjoo KN, George S, Gonzalez RJ, Heslin MJ, Kane JM 3rd, Koon H, Mayerson J, McCarter M, McGarry SV, Meyer C, O'Donnell RJ, Pappo AS, Paz IB, Petersen IA, Pfeifer JD, Riedel RF, Schuetze S, Schupak KD, Schwartz HS, Tap WD, Wayne JD, Bergman MA, Scavone J.

J Natl Compr Canc Netw. 2016 Jun;14(6):758-86.

PMID:
27283169
10.

Sarcopenia Does Not Affect Survival or Outcomes in Soft-Tissue Sarcoma.

Wilson RJ, Alamanda VK, Hartley KG, Mesko NW, Halpern JL, Schwartz HS, Holt GE.

Sarcoma. 2015;2015:146481. doi: 10.1155/2015/146481. Epub 2015 Dec 1.

11.

Fibrinolysis is essential for fracture repair and prevention of heterotopic ossification.

Yuasa M, Mignemi NA, Nyman JS, Duvall CL, Schwartz HS, Okawa A, Yoshii T, Bhattacharjee G, Zhao C, Bible JE, Obremskey WT, Flick MJ, Degen JL, Barnett JV, Cates JM, Schoenecker JG.

J Clin Invest. 2015 Sep;125(9):3723. doi: 10.1172/JCI84059. Epub 2015 Sep 1. No abstract available.

12.

Fibrinolysis is essential for fracture repair and prevention of heterotopic ossification.

Yuasa M, Mignemi NA, Nyman JS, Duvall CL, Schwartz HS, Okawa A, Yoshii T, Bhattacharjee G, Zhao C, Bible JE, Obremskey WT, Flick MJ, Degen JL, Barnett JV, Cates JM, Schoenecker JG.

J Clin Invest. 2015 Aug 3;125(8):3117-31. doi: 10.1172/JCI80313. Epub 2015 Jul 27. Erratum in: J Clin Invest. 2015 Sep;125(9):3723.

13.

Histoplasmosis Masquerading as a Rheumatoid Nodule in an Immunocompromised Host: A Case Report.

Pettit AC, Raynor MB, Schwartz HS, Wright PW.

JBJS Case Connect. 2014;4(3). pii: e75. No abstract available.

14.

Overutilization and Cost of Advanced Imaging for Long-Bone Cartilaginous Lesions.

Wilson RJ, Zumsteg JW, Hartley KA, Long JH, Mesko NW, Halpern JL, Schwartz HS, Holt GE.

Ann Surg Oncol. 2015 Oct;22(11):3466-73. doi: 10.1245/s10434-014-4325-y. Epub 2015 Jan 7.

PMID:
25564171
15.

MFH and high-grade undifferentiated pleomorphic sarcoma-what's in a name?

Delisca GO, Mesko NW, Alamanda VK, Archer KR, Song Y, Halpern JL, Schwartz HS, Holt GE.

J Surg Oncol. 2015 Feb;111(2):173-7. doi: 10.1002/jso.23787. Epub 2014 Sep 12.

PMID:
25219789
16.

Histoplasmosis Masquerading as a Rheumatoid Nodule in an Immunocompromised Host: A Case Report.

Pettit AC, Raynor MB, Schwartz HS, Wright PW.

JBJS Case Connect. 2014 Sep 10;4(3):e75-e5. doi: 10.2106/JBJS.CC.M.00277. No abstract available.

PMID:
29252295
17.

Medical malpractice and sarcoma care--a thirty-three year review of case resolutions, inciting factors, and at risk physician specialties surrounding a rare diagnosis.

Mesko NW, Mesko JL, Gaffney LM, Halpern JL, Schwartz HS, Holt GE.

J Surg Oncol. 2014 Dec;110(8):919-29. doi: 10.1002/jso.23770. Epub 2014 Aug 22.

PMID:
25155556
18.

The temporal and spatial development of vascularity in a healing displaced fracture.

Yuasa M, Mignemi NA, Barnett JV, Cates JM, Nyman JS, Okawa A, Yoshii T, Schwartz HS, Stutz CM, Schoenecker JG.

Bone. 2014 Oct;67:208-21. doi: 10.1016/j.bone.2014.07.002. Epub 2014 Jul 10.

PMID:
25016962
19.

Gastrointestinal stromal tumors, version 2.2014.

von Mehren M, Randall RL, Benjamin RS, Boles S, Bui MM, Casper ES, Conrad EU 3rd, DeLaney TF, Ganjoo KN, George S, Gonzalez RJ, Heslin MJ, Kane JM 3rd, Mayerson J, McGarry SV, Meyer C, O'Donnell RJ, Pappo AS, Paz IB, Pfeifer JD, Riedel RF, Schuetze S, Schupak KD, Schwartz HS, Van Tine BA, Wayne JD, Bergman MA, Sundar H.

J Natl Compr Canc Netw. 2014 Jun;12(6):853-62.

PMID:
24925196
20.

Obesity does not affect survival outcomes in extremity soft tissue sarcoma.

Alamanda VK, Moore DC, Song Y, Schwartz HS, Holt GE.

Clin Orthop Relat Res. 2014 Sep;472(9):2799-806. doi: 10.1007/s11999-014-3714-7. Epub 2014 Jun 6.

21.

Micro-computed tomography derived anisotropy detects tumor provoked deviations in bone in an orthotopic osteosarcoma murine model.

Cole HA, Ohba T, Ichikawa J, Nyman JS, Cates JM, Haro H, Schwartz HS, Schoenecker JG.

PLoS One. 2014 Jun 3;9(6):e97381. doi: 10.1371/journal.pone.0097381. eCollection 2014.

22.

Postoperative radiation boost does not improve local recurrence rates in extremity soft tissue sarcomas.

Alamanda VK, Song Y, Shinohara E, Schwartz HS, Holt GE.

J Med Imaging Radiat Oncol. 2014 Oct;58(5):633-40. doi: 10.1111/1754-9485.12184. Epub 2014 May 13.

PMID:
24821569
23.

Autocrine VEGF/VEGFR1 signaling in a subpopulation of cells associates with aggressive osteosarcoma.

Ohba T, Cates JM, Cole HA, Slosky DA, Haro H, Ando T, Schwartz HS, Schoenecker JG.

Mol Cancer Res. 2014 Aug;12(8):1100-11. doi: 10.1158/1541-7786.MCR-14-0037. Epub 2014 Apr 23.

24.

Soft tissue sarcoma, version 2.2014.

von Mehren M, Randall RL, Benjamin RS, Boles S, Bui MM, Casper ES, Conrad EU 3rd, Delaney TF, Ganjoo KN, George S, Gonzalez RJ, Heslin MJ, Kane JM 3rd, Mayerson J, McGarry SV, Meyer C, O'Donnell RJ, Pappo AS, Paz IB, Pfeifer JD, Riedel RF, Schuetze S, Schupak KD, Schwartz HS, Van Tine BA, Wayne JD, Bergman MA, Sundar H; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2014 Apr;12(4):473-83.

PMID:
24717567
25.

Pleiotropic effects of bisphosphonates on osteosarcoma.

Ohba T, Cates JM, Cole HA, Slosky DA, Haro H, Ichikawa J, Ando T, Schwartz HS, Schoenecker JG.

Bone. 2014 Jun;63:110-20. doi: 10.1016/j.bone.2014.03.005. Epub 2014 Mar 14.

PMID:
24636958
26.

Bisphosphonates inhibit osteosarcoma-mediated osteolysis via attenuation of tumor expression of MCP-1 and RANKL.

Ohba T, Cole HA, Cates JM, Slosky DA, Haro H, Ando T, Schwartz HS, Schoenecker JG.

J Bone Miner Res. 2014 Jun;29(6):1431-45. doi: 10.1002/jbmr.2182.

27.

Racial Disparities in Extremity Soft-Tissue Sarcoma Outcomes: A Nationwide Analysis.

Alamanda VK, Song Y, Schwartz HS, Holt GE.

Am J Clin Oncol. 2015 Dec;38(6):595-9. doi: 10.1097/COC.0000000000000004.

PMID:
24401671
28.

Does postoperative infection after soft tissue sarcoma resection affect oncologic outcomes?

Behnke NK, Alamanda VK, Song Y, Archer KR, Halpern JL, Schwartz HS, Holt GE.

J Surg Oncol. 2014 Apr;109(5):415-20. doi: 10.1002/jso.23518. Epub 2013 Nov 28.

PMID:
24284805
29.

Incomplete excisions of extremity soft tissue sarcomas are unaffected by insurance status or distance from a sarcoma center.

Alamanda VK, Delisca GO, Archer KR, Song Y, Schwartz HS, Holt GE.

J Surg Oncol. 2013 Dec;108(7):477-80. doi: 10.1002/jso.23427. Epub 2013 Sep 4.

PMID:
24006266
30.

The financial burden of reexcising incompletely excised soft tissue sarcomas: a cost analysis.

Alamanda VK, Delisca GO, Mathis SL, Archer KR, Ehrenfeld JM, Miller MW, Homlar KC, Halpern JL, Schwartz HS, Holt GE.

Ann Surg Oncol. 2013 Sep;20(9):2808-14. doi: 10.1245/s10434-013-2995-5. Epub 2013 Apr 30.

PMID:
23636515
31.

Tumor size increase following preoperative radiation of soft tissue sarcomas does not affect prognosis.

Delisca GO, Alamanda VK, Archer KR, Song Y, Schwartz HS, Holt GE.

J Surg Oncol. 2013 Jun;107(7):723-7. doi: 10.1002/jso.23322. Epub 2013 Feb 11.

PMID:
23400806
32.

Signal transduction pathway analysis in desmoid-type fibromatosis: transforming growth factor-β, COX2 and sex steroid receptors.

Mignemi NA, Itani DM, Fasig JH, Keedy VL, Hande KR, Whited BW, Homlar KC, Correa H, Coffin CM, Black JO, Yi Y, Halpern JL, Holt GE, Schwartz HS, Schoenecker JG, Cates JM.

Cancer Sci. 2012 Dec;103(12):2173-80. doi: 10.1111/cas.12037. Epub 2012 Nov 15.

33.

Amputation for extremity soft tissue sarcoma does not increase overall survival: a retrospective cohort study.

Alamanda VK, Crosby SN, Archer KR, Song Y, Schwartz HS, Holt GE.

Eur J Surg Oncol. 2012 Dec;38(12):1178-83. doi: 10.1016/j.ejso.2012.08.024. Epub 2012 Sep 15.

PMID:
22985713
34.

Staples equal sutures for skin closure after soft tissue tumor resection.

Moore DC, Sellers MH, Archer KR, Schwartz HS, Holt GE.

Clin Orthop Relat Res. 2013 Mar;471(3):899-904. doi: 10.1007/s11999-012-2524-z.

35.

Soft tissue sarcoma, version 2.2012: featured updates to the NCCN guidelines.

von Mehren M, Benjamin RS, Bui MM, Casper ES, Conrad EU 3rd, DeLaney TF, Ganjoo KN, George S, Gonzalez R, Heslin MJ, Kane JM 3rd, Mayerson J, McGarry SV, Meyer C, O'Donnell RJ, Paz B, Pfeifer JD, Pollock RE, Randall RL, Riedel RF, Schuetze S, Schupak KD, Schwartz HS, Shankar S, Van Tine BA, Wayne J, Sundar H, McMillian NR.

J Natl Compr Canc Netw. 2012 Aug;10(8):951-60.

PMID:
22878820
36.

Predictors and clinical significance of local recurrence in extremity soft tissue sarcoma.

Alamanda VK, Crosby SN, Archer KR, Song Y, Schwartz HS, Holt GE.

Acta Oncol. 2013 May;52(4):793-802. doi: 10.3109/0284186X.2012.711953. Epub 2012 Aug 9.

PMID:
22877243
37.

Nuclear p63 expression in osteoblastic tumors.

Kallen ME, Sanders ME, Gonzalez AL, Black JO, Keedy VL, Hande KR, Homlar KC, Halpern JL, Holt GE, Schwartz HS, Coffin CM, Cates JM.

Tumour Biol. 2012 Oct;33(5):1639-44. doi: 10.1007/s13277-012-0419-y. Epub 2012 May 25.

PMID:
22623071
38.

Signal transduction pathway analysis in fibromatosis: receptor and nonreceptor tyrosine kinases.

Cates JM, Black JO, Itani DM, Fasig JH, Keedy VL, Hande KR, Whited BW, Homlar KC, Halpern JL, Holt GE, Schwartz HS, Coffin CM.

Hum Pathol. 2012 Oct;43(10):1711-8. doi: 10.1016/j.humpath.2011.12.021. Epub 2012 Apr 18.

39.

Morphologic and immunophenotypic analysis of desmoid-type fibromatosis after radiation therapy.

Cates JM, Black J, Wolfe CC, Shinohara ET, Holt GE, Keedy VL, Hande KR, Homlar KC, Halpern JL, Schwartz HS, Troutman A, Coffin CM.

Hum Pathol. 2012 Sep;43(9):1418-24. doi: 10.1016/j.humpath.2011.11.002. Epub 2012 Mar 8.

PMID:
22404950
40.

Primary excision compared with re-excision of extremity soft tissue sarcomas--is anything new?

Alamanda VK, Crosby SN, Archer KR, Song Y, Schwartz HS, Holt GE.

J Surg Oncol. 2012 Jun 1;105(7):662-7. doi: 10.1002/jso.23021. Epub 2011 Dec 27.

PMID:
22213171
41.

Thrombin induces osteosarcoma growth, a function inhibited by low molecular weight heparin in vitro and in vivo: procoagulant nature of osteosarcoma.

Ichikawa J, Cole HA, Magnussen RA, Mignemi NA, Butler M, Holt GE, O'Rear L, Yuasa M, Pabla B, Haro H, Cates JM, Hamm HE, Schwartz HS, Schoenecker JG.

Cancer. 2012 May 1;118(9):2494-506. doi: 10.1002/cncr.26518. Epub 2011 Sep 27.

42.

Incidence of symptomatic venous thromboembolism in oncologic patients undergoing lower-extremity endoprosthetic arthroplasty.

Ramo BA, Griffin AM, Gill CS, McDonald DJ, Wunder JS, Ferguson P, Bell RS, Phillips SE, Schwartz HS, Holt GE.

J Bone Joint Surg Am. 2011 May 4;93(9):847-54. doi: 10.2106/JBJS.H.01640.

PMID:
21543674
43.

Popliteal artery aneurysm simulating soft tissue sarcoma.

Wood JH, Borkon MJ, Schwartz HS, Dattilo JB.

Am Surg. 2010 Aug;76(8):E106-7. No abstract available.

PMID:
21513623
44.

Extrarenal rhabdoid tumor mimicking a sacral peripheral nerve sheath tumor.

Dobbs MD, Correa H, Schwartz HS, Kan JH.

Skeletal Radiol. 2011 Oct;40(10):1363-8. doi: 10.1007/s00256-011-1160-0. Epub 2011 Apr 9.

PMID:
21479516
45.

Popliteal Artery Aneurysm Simulating Soft Tissue Sarcoma.

Wood JH, Borkon MJ, Schwartz HS, Dattilo JB.

Am Surg. 2010 Aug 1;76(8):106-107. No abstract available.

PMID:
28958222
46.

Soft tissue sarcoma.

Demetri GD, Antonia S, Benjamin RS, Bui MM, Casper ES, Conrad EU 3rd, DeLaney TF, Ganjoo KN, Heslin MJ, Hutchinson RJ, Kane JM 3rd, Letson GD, McGarry SV, O'Donnell RJ, Paz IB, Pfeifer JD, Pollock RE, Randall RL, Riedel RF, Schupak KD, Schwartz HS, Thornton K, von Mehren M, Wayne J; National Comprehensive Cancer Network Soft Tissue Sarcoma Panel.

J Natl Compr Canc Netw. 2010 Jun;8(6):630-74. No abstract available.

PMID:
20581298
47.

Metastatic bone disease: diagnosis, evaluation, and treatment.

Biermann JS, Holt GE, Lewis VO, Schwartz HS, Yaszemski MJ.

Instr Course Lect. 2010;59:593-606.

PMID:
20415408
48.

Proteomic analysis of osteogenic sarcoma: association of tumour necrosis factor with poor prognosis.

Cates JM, Friedman DB, Seeley EH, Dupont WD, Schwartz HS, Holt GE, Caprioli RM, Young PP.

Int J Exp Pathol. 2010 Aug;91(4):335-49. doi: 10.1111/j.1365-2613.2010.00711.x. Epub 2010 Mar 26.

49.

Metal-backed versus all-polyethylene tibias in megaprostheses of the distal femur.

Crosby SN, Polkowski GG, Schwartz HS, Shinar AA, Holt GE.

J Arthroplasty. 2011 Apr;26(3):451-7. doi: 10.1016/j.arth.2010.01.007. Epub 2010 Mar 23.

PMID:
20334995
50.

Methylthioadenosine phosphorylase and activated insulin-like growth factor-1 receptor/insulin receptor: potential therapeutic targets in chordoma.

Sommer J, Itani DM, Homlar KC, Keedy VL, Halpern JL, Holt GE, Schwartz HS, Coffin CM, Kelley MJ, Cates JM.

J Pathol. 2010 Apr;220(5):608-17. doi: 10.1002/path.2679.

PMID:
20140939

Supplemental Content

Loading ...
Support Center